CAMP4 is a drug discovery and development platform for researchers with a focus on RNA therapies.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/20/2022 | Series B | $100.49MM | $xx.xx | $298.37MM | Patient Square Capital, Gaingels, 5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group | |
Price per Share
$xx.xx
Shares Outstanding
68,251,844
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Patient Square Capital, Gaingels, 5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group
|
||||||
06/15/2021 | Series A Prime | $14.45MM | $xx.xx | $36.13MM | 5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group | |
Price per Share
$xx.xx
Shares Outstanding
68,173,692
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
5AM Ventures, Polaris Partners, Northpond Ventures, Andreessen Horowitz, The Kraft Group
|